Additionally, T cells from SLE patients had higher autophagic activity than that from controls after anti-CD3/CD28 stimulation (48.07 ± 1.51 versus 37.00 ± 1.00, p = 0.0077 for CD3+T cells; 50.38 ± 3.02 versus 33.20 ± 2.30, p = 0.0213 for CD4+T cells; 51.64 ± 1.10 versus 41.20 ± 5.20, p = 0.0254 for CD8+T cells) (Figure 2). The gene discussed is CD28; the disease is systemic lupus erythematosus.